These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11673034)

  • 41. [Ventilator-associated pneumonia; controversies with respect to diagnosis, pathogenesis, therapy and prevention].
    Bonten MJ; Bergmans DC; Hoepelman IM; Stobberingh EE
    Ned Tijdschr Geneeskd; 1999 Apr; 143(14):726-30. PubMed ID: 10347627
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.
    Chastre J; Wolff M; Fagon JY; Chevret S; Thomas F; Wermert D; Clementi E; Gonzalez J; Jusserand D; Asfar P; Perrin D; Fieux F; Aubas S;
    JAMA; 2003 Nov; 290(19):2588-98. PubMed ID: 14625336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Continuous versus intermittent endotracheal cuff pressure control for the prevention of ventilator-associated respiratory infections in Vietnam: study protocol for a randomised controlled trial.
    Dat VQ; Geskus RB; Wolbers M; Loan HT; Yen LM; Binh NT; Chien LT; Mai NTH; Phu NH; Lan NPH; Hao NV; Long HB; Thuy TP; Kinh NV; Trung NV; Phu VD; Cap NT; Trinh DT; Campbell J; Kestelyn E; Wertheim HFL; Wyncoll D; Thwaites GE; van Doorn HR; Thwaites CL; Nadjm B
    Trials; 2018 Apr; 19(1):217. PubMed ID: 29615093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ventilator-associated pneumonia: monotherapy is optimal if chosen wisely.
    Cunha BA
    Crit Care; 2006; 10(2):141. PubMed ID: 16677419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical approach to the patient with suspected ventilator-associated pneumonia.
    Vidaur L; Sirgo G; Rodríguez AH; Rello J
    Respir Care; 2005 Jul; 50(7):965-74; discussion 974. PubMed ID: 15972116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prior antimicrobial therapy duration influences causative pathogens identification in ventilator-associated pneumonia.
    Llitjos JF; Amara M; Benzarti A; Lacave G; Bedos JP; Pangon B
    J Crit Care; 2018 Feb; 43():375-377. PubMed ID: 29113712
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nosocomial pneumonia in the ICU--year 2000 and beyond.
    Bowton DL
    Chest; 1999 Mar; 115(3 Suppl):28S-33S. PubMed ID: 10084457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibiotic prophylaxis strategies in the prevention of ventilator-associated pneumonia.
    Sirvent JM; Torres A
    Expert Opin Pharmacother; 2003 Aug; 4(8):1345-54. PubMed ID: 12877642
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ventilator-associated pneumonia: insights from recent clinical trials.
    Shorr AF; Kollef MH
    Chest; 2005 Nov; 128(5 Suppl 2):583S-591S. PubMed ID: 16306057
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.
    Shorr AF; Combes A; Kollef MH; Chastre J
    Crit Care Med; 2006 Mar; 34(3):700-6. PubMed ID: 16505656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanical ventilator as a major cause of infection and drug resistance in intensive care unit.
    Abd-Elmonsef MME; Elsharawy D; Abd-Elsalam AS
    Environ Sci Pollut Res Int; 2018 Nov; 25(31):30787-30792. PubMed ID: 28233206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibiotic resistance of bacterial ventilator-associated pneumonia in surgical intensive care units.
    Namiduru M; Güngör G; Karaoğlan I; Dikensoy O
    J Int Med Res; 2004; 32(1):78-83. PubMed ID: 14997711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nosocomial pneumonia.
    Myrianthefs PM; Kalafati M; Samara I; Baltopoulos GJ
    Crit Care Nurs Q; 2004; 27(3):241-57. PubMed ID: 15291050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of antibiotic-resistant bacteria on the outcome of ventilator-associated pneumonia.
    Combes A; Luyt CE; Trouillet JL
    Semin Respir Crit Care Med; 2006 Feb; 27(1):23-8. PubMed ID: 16508878
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ventilator-associated pneumonia due to Pseudomonas aeruginosa.
    Crouch Brewer S; Wunderink RG; Jones CB; Leeper KV
    Chest; 1996 Apr; 109(4):1019-29. PubMed ID: 8635325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel and innovative strategies to treat ventilator-associated pneumonia: optimizing the duration of therapy and nebulizing antimicrobial agents.
    Goldstein I; Chastre J; Rouby JJ
    Semin Respir Crit Care Med; 2006 Feb; 27(1):82-91. PubMed ID: 16508884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aetiology of hospital-acquired pneumonia and trends in antimicrobial resistance.
    Enne VI; Personne Y; Grgic L; Gant V; Zumla A
    Curr Opin Pulm Med; 2014 May; 20(3):252-8. PubMed ID: 24614243
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current concepts in the prevention and treatment of ventilator-associated pneumonia.
    Micek ST; Skrupky LP
    J Pharm Pract; 2010 Feb; 23(1):25-32. PubMed ID: 21507790
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibiotic utilization and outcomes for patients with clinically suspected ventilator-associated pneumonia and negative quantitative BAL culture results.
    Kollef MH; Kollef KE
    Chest; 2005 Oct; 128(4):2706-13. PubMed ID: 16236946
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ventilator-associated pneumonia: gearing towards shorter-course therapy.
    Chua Tde J; File TM
    Curr Opin Infect Dis; 2006 Apr; 19(2):185-8. PubMed ID: 16514344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.